
Latanoprost
Latanoprost is a prostaglandin Falpha that is the isopropyl ester prodrug of latanoprost free acid. Used in the treatment of open-angle glaucoma and ocular hypertension. It has a role as an EC 4.2.1.1 (carbonic anhydrase) inhibitor, an antihypertensive agent, an antiglaucoma drug and a prodrug. It is a triol, an isopropyl ester and a prostaglandins Falpha. It is functionally related to a latanoprost free acid. — ChEBI
- IUPAC-Name
- propan-2-yl (Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl]hept-5-enoate
- Summenformel
- C26H40O5
- Molekulargewicht
- 432.6 g/mol
- Exakte Masse
- 432.28757437 Da
- XLogP3
- 4,3
- Topologische polare Oberfläche
- 87,0 Ų
- Wasserstoffbrücken-Donoren
- 3
- Wasserstoffbrücken-Akzeptoren
- 5
- Kovalente Einheiten
- 1
- Definierte Stereozentren
- 5
Auch bekannt als
16 weitere gemeldete Namen
Kennungen in externen Datenbanken
- ChEBI:CHEBI:6384
- ChEMBL:CHEMBL1051
- EPA DTXSID:DTXSID1041057
- PubMed:29921209
- PubMed:25811541
- PubMed:25328381
- PubMed:23956101
- PubMed:20019365
- PubMed:19403113
- PubMed:18721251
- PubMed:18166407
- PubMed:17539800
- PubMed:17459480
- PubMed:17416939
- PubMed:17102001
Belege aus weiteren wissenschaftlichen Datenbanken
NIH PubChem PUG-View
Attributed physical-property, hazard, environmental and use annotations.
- Boiling Point: 583.8 Quelle: DrugBank
- pKa: 4.88 Quelle: DrugBank
- LogP: 3.98 Quelle: DrugBank
- LogP: 4.4 Quelle: Human Metabolome Database (HMDB)
- Physical Description: Liquid Quelle: Human Metabolome Database (HMDB)
- Solubility: 1.29e-02 g/L Quelle: Human Metabolome Database (HMDB)
- Note: This chemical does not meet GHS hazard criteria for 0.7% (1 of 145) of reports. Quelle: European Chemicals Agency (ECHA)
- Signal: Danger Quelle: European Chemicals Agency (ECHA)
- GHS Hazard Statements: H300 (63.4%): Fatal if swallowed [Danger Acute toxicity, oral]; H301 (11%): Toxic if swallowed [Danger Acute toxicity, oral]; H361 (62.1%): Suspected of damaging fertility or the unborn child [Warning Reproductive toxicity] Quelle: European Chemicals Agency (ECHA)
- Precautionary Statement Codes: P203, P264, P270, P280, P301+P316, P318, P321, P330, P405, and P501 (click each P-code to see the statement) Quelle: European Chemicals Agency (ECHA)
- ECHA C&L Notifications Summary: Aggregated GHS information provided per 145 reports by companies from 16 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.; Reported as not meeting GHS hazard criteria per 1 of 145 reports by companies.; There are 15 notifications provided by 144 of 145 reports by companies with hazard statement code(s).; Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website. Quelle: European Chemicals Agency (ECHA)
- Toxicity Summary: Researchers found no carcinogenesis or mutagenesis with latanoprost, and the drug did not affect fertility in animal studies. However, latanoprost was noted to cause a chromosomal aberration in treated human lymphocytes. Intravenous infusion of 3 μg/kg of latanoprost in healthy volunteers produced plasma concentrations 200 times higher than during clinical treatment with latanoprost ophthalmic solution, and researchers identified no ADR. There is no evidence to establish a correlation between latanoprost administration and ocular or cutaneous melanoma.; Intravenous infusion of 5.5 to 10 μg/kg resulted in fatigue, sweating, dizziness, nausea, and abdominal pain. According to the manufacturer's labeling, treatment should be symptomatic if there is an overdosage with latanoprost ophthalmic solution. Quelle: StatPearls
- Uses: Use (kg) in USA (2002): 1; Consumption (g per capita) in the USA (2002): 3.3e-06; Calculated removal (%): 100 Quelle: NORMAN Suspect List Exchange
Zugeordnet durch: Existing checksum-valid CAS to unique PubChem CID match. Abgerufen: 2026-08-31. Quelleneintrag öffnen
Wissenschaftliche Klassifizierungen und Gefahrenannotationen liefern Kontext und ersetzen nicht die oben gezeigte marktspezifische regulatorische Entscheidung.
Weitere Quellenabdeckung und Trefferstatus
| Quelle | Ergebnis | Geprüft |
|---|---|---|
| NIH PubChem PUG-View | Exakter Treffer | 2026-08-31 |
Ein erfasster Nicht-Treffer ist ein nützlicher Beleg dafür, dass die Quelle geprüft wurde; er ist keine Behauptung, dass der Stoff anderswo nicht existiert.
Am 2026-08-31 von NIH PubChem durch prüfsummengültigen CAS-Abgleich abgerufen. Chemische Eigenschaften ersetzen nicht die regulatorische Entscheidung auf dieser Seite.